Table: Sawai Pharmaceutical -6-MTH group results
Nov 6 (Reuters)-
Sawai Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2015 Sep 30, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 58.96 50.20 124.00
(+17.4 pct) (+17.4 pct) (+17.6 pct)
Operating 11.61 10.23 22.00
(+13.5 pct) (+1.7 pct) (+6.3 pct)
Recurring 11.44 10.18 21.70
(+12.4 pct) (+0.2 pct) (+5.2 pct)
Net 8.50 7.00 15.50
(+21.4 pct) (+8.0 pct) (+10.3 pct)
EPS 230.76 yen 190.40 yen 420.85 yen
EPS Diluted 230.57 yen 190.21 yen
Ann Div 105.00 yen 110.00 yen
-Q2 div 55.00 yen 50.00 yen
-Q4 div 55.00 yen 55.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)